Occult metastases: Real harm or false alarm?

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 2, 2003, Pages 332-333

  Cote, Richard J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HUMAN; LUNG CANCER; LYMPH NODE METASTASIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

EID: 0042856683     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(02)73590-3     Document Type: Editorial

References (13)

1. Marchevsky AM, Qiao J-H, Krajisnik S, Minocha JM, McKenna RJ. The prognostic significance of intranodal isolated tumor cells and micrometastases in patients with non-small cell carcinoma of the lung. J Thorac Cardiovasc Surg. 2003;126:551-7.
2. Fisher B, Slack N, Katrych D, Wolmark N. Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet. 1975;140:528-34.
3. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP, Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer. 1980;45:2917-24.
4. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst. 1999;91:1113-24.
5. Cote R, Hawes D, Chaiwun B, Beattie EJ. Detection of occult metastases in lung carcinomas: progress and implications for staging. J Surg Oncol. 1998;69:265-74.
6. Hawes D, Neville AM, Cote RJ. Occult metastases in patients with breast cancer. Ann Surg Oncol. 2001;8:60-3.
7. Cote RJ, Peterson HF, Chaiwun B, et al. Role of the immunohistochemical detection of lymph nodes metastases in the management of breast cancer. Lancet. 1999;354:896-900.
8. Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol. 1999;17:19-24.
9. Chatterjee SJ, Hawes D, Taylor CR, Neville AM, Cote RJ. Occult metastases. In: Silberman H, Silberman AW, editors. Surgical oncology; multidisciplinary approach to difficult problems. New York (NY): Oxford University Press; 2002. p. 69-97.
10. Pantel K, Izbicki J, Passlick B, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet. 1996;347:649-53.
11. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastasis. J Clin Oncol. 1991;9:1749-56.
12. Braun S, Pantel K, Muller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, of III breast cancer. N Engl J Med. 2000;342:525-33.
13. Cote RJ, Beattie EJ, Chaiwun B, et al. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg. 1995;222:415-25.